Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director · Chairman | October 29, 2007 | October 31, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date October 29, 2007 · Filed October 31, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 135,572 |
Reported balance
After 2007-10-29 transaction · row 1
1 source rowRow 1 · 2007-10-29 · Grant · Acquired 23 · Balance 135,572 F1: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TEAM HEALTH HOLDINGS INC.
Report date February 06, 2017 · Filed February 08, 2017
Section 16 reporting ended · disclosed 2017-02-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 1
1 source rowRow 1 · 2017-02-06 · Disposition to issuer · Disposed 82,251 · Balance 0 F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-02-06 · Disposition to issuer · Disposed 2,841 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Company. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y)$43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 25, 2016 grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Company.
F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y)$43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person.
F4: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 25, 2016 grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2017 Filed Feb 8, 2017 20:34 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 2,841 | $43.50 | $123,583.50 |
DisclosureSEC source: 0000899243-17-003208 · doc4.xml · derivative · entry 2 CRAWFORD EDWIN M · CIK 0001197677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,841 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Company. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y)$43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y)$43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4 · derivative.exercise_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 25, 2016 grant date. F4 · derivative.expiration_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 25, 2016 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:34 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerCommon Stock | 82,251 | $43.50 | $3,577,918.50 |
DisclosureSEC source: 0000899243-17-003208 · doc4.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. F1 · price: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000157 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,572 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 51 | $39.19 | $1,998.69 |
DisclosureSEC source: 0000064803-07-000150 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,549 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| September 04, 2007 Filed Sep 4, 2007 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 400,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · derivative · entry 11 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,594,611 Underlying: Common Stock · 400,000 shares Expires 2010-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| September 04, 2007 Filed Sep 4, 2007 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 400,000 | $38.16 | $15,264,040.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · nonDerivative · entry 4 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,498 Read SEC document |
| September 04, 2007 Filed Sep 4, 2007 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 400,000 | $2.37 | $948,000.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · nonDerivative · entry 3 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 800,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · derivative · entry 10 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,994,611 Underlying: Common Stock · 800,000 shares Expires 2010-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 800,000 | $37.67 | $30,135,040.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · nonDerivative · entry 2 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,498 Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 800,000 | $2.37 | $1,896,000.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2007 Filed Jul 12, 2007 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.18 | $976.86 |
DisclosureSEC source: 0000064803-07-000133 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,498 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| June 26, 2007 Filed Jun 27, 2007 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $35.86 | $968.22 |
DisclosureSEC source: 0000064803-07-000126 · doc.xml · nonDerivative · entry 2 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,471 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| June 25, 2007 Filed Jun 27, 2007 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.31 | $980.37 |
DisclosureSEC source: 0000064803-07-000126 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,444 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| May 09, 2007 Filed May 10, 2007 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,817 | $38.02 | $69,082.34 |
DisclosureSEC source: 0000064803-07-000098 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,417 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 843,164 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 7 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 843,164 Underlying: Common Stock · 843,392 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 1,405,799 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 6 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,405,799 Underlying: Common Stock · 1,405,799 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 1,124,153 | $0.00 Strike: $17.08 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 5 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,153 Underlying: Common Stock · 1,124,153 shares Expires 2014-05-10 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 3,017,937 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 4 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017,937 Underlying: Common Stock · 3,017,937 shares Expires 2011-08-28 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 3,794,611 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 3 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,794,611 Underlying: Common Stock · 3,794,611 shares Expires 2010-03-08 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 1,874 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · derivative · entry 2 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,874 Underlying: Common Stock · 1,874 shares Expires 2008-09-21 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 133,600 | $34.80 | $4,649,280.00 |
DisclosureSEC source: 0000064803-07-000062 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,600 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 843,164 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · derivative · entry 7 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 843,164 Underlying: Common Stock · 843,164 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 1,405,799 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · derivative · entry 6 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,405,799 Underlying: Common Stock · 1,405,799 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 1,124,153 | $0.00 Strike: $17.08 | $0.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · derivative · entry 5 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,153 Underlying: Common Stock · 1,124,153 shares Expires 2014-05-10 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 3,017,937 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · derivative · entry 4 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017,937 Underlying: Common Stock · 3,017,937 shares Expires 2011-08-28 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 3,794,611 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · derivative · entry 3 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,794,611 Underlying: Common Stock · 3,794,611 shares Expires 2010-03-08 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 1,874 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · derivative · entry 2 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,874 Underlying: Common Stock · 1,874 shares Expires 2008-09-21 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 133,600 | $34.80 | $4,649,280.00 |
DisclosureSEC source: 0000064803-07-000071 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,600 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.